Thyrocare Technologies Ltd
NSE:THYROCARE
Operating Margin
Thyrocare Technologies Ltd
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| IN |
|
Thyrocare Technologies Ltd
NSE:THYROCARE
|
52.2B INR |
20%
|
|
| US |
C
|
Cigna Group
XMUN:CGN
|
75.5B EUR |
4%
|
|
| US |
|
Cigna Corp
NYSE:CI
|
86.5B USD |
4%
|
|
| US |
|
CVS Health Corp
NYSE:CVS
|
84B USD |
3%
|
|
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
28.5B EUR |
7%
|
|
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
23.8B EUR |
9%
|
|
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
21.8B USD |
9%
|
|
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
19.8B USD |
14%
|
|
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
14.3B EUR |
7%
|
|
| US |
|
DaVita Inc
NYSE:DVA
|
11B USD |
15%
|
|
| US |
|
Hims & Hers Health Inc
NYSE:HIMS
|
10.6B USD |
6%
|
Thyrocare Technologies Ltd
Glance View
Thyrocare Technologies Ltd. engages in provison of indepedent diagnostic and pathological laboratory services. The company is headquartered in Navi Mumbai, Maharashtra and currently employs 2,115 full-time employees. The company went IPO on 2016-05-09. The firm operates with a centralized processing laboratory (CPL) in Mumbai, India for esoteric tests, and regional processing laboratory in metro cities of India and other parts of Asia. The firm offers technologies, including Chemiluminescence Immunoassay (CLIA), Enzyme Linked Immunosorbent Assay (ELISA), High Performance Liquid Chromatography (HPLC), Capillary Electrophoresis (CE), Ion Selective Electrode (ISE), Fluorescence Flow Cytometry, Nephelometry, Photometry, Liquid Chromatography Mass Spectrometry (LC-MS), Inductively Coupled Plasma-Mass Spectrometry (ICP-MS) and Cytogenetics. The firm offers various kinds of tests, such as Aarogyam X, Aarogyam XL, Aarogyam 1.1, Aarogyam 1.2 and Covid Antibody GT. The company also offers Thyroxine (T4), Triiodothyronine (T3), Thyroid-stimulating hormone and Complete Vitamin Profile tests.
See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Thyrocare Technologies Ltd's most recent financial statements, the company has Operating Margin of 19.7%.
You don't have any saved screeners yet